Supported by

LAA (Left Atrial Appendage) closure

Here you will find all the latest content on left atrial appendage (LAA) closure published on this website. Results are listed in chronological order.

Today, with an aging population, atrial fibrillation is more common and carries with it an increased risk of embolic cerebrovascular accidents. Anticoagulation strategies alone are not sufficient, and as a large proportion of the thrombus involved in these cerebrovascular accidents are seen to arise in the left atrial appendage (LAA), its closure, either surgically or by percutaneous methods, could reduce risk. Learn more about imaging, tools, devices and techniques as well as adjunctive pharmacotherapy, vascular access and bleeding here…

Filtered By
LAA closure

57 results

Watchman™ Ewolution prospective registry - 3 months results & clinical impact

Authors :

Prof. Martin W. Bergmann

LAA closure with imaging guidance

From the very beginning of LAA closure, imaging plays a central role which is touched on in this wide-ranging discussion led by O. Muller with S. Berti and F. Hellig. To understand the complex anatomy of the left atrial appendage we need to effectively use imaging, even before the intervention begins.

Again, we depend on imaging to see if there is thrombus present, or to plan our clinical strategy or afterwards to judge the efficacy of our intervention – but what are the minimum imaging modalities we need to in order to safely perform LAA closure? What imaging technologies are employed today, and are there new ones emerging? How do we integrate the different imaging technologies into our clinical approach during closure?

LAA closure for stroke prevention: current indications and results

Delve into the history of LAA closure and learn when and why an alternative for warfarin use was needed as E. Eeckhout and F. Hellig discuss the state of the art concerning the left atrial appendage and the main indications for its percutaneous closure. What role does the bleeding risk profile of your patient play? Have the early complications we saw with LAA closure diminished? What do we expect for the future, especially concerning medication?

LIVE case: LAA closure

From EuroPCR 2016

With the collaboration of Montreal Live

Relive the LIVE case from the Swiss Cardiovascular Center in Bern University Hospital focusing on LAA-closure with the AMPLATZER Amulet as alternative to oral anticoagulation in patients undergoing PCI.

A 79-year-old male with paroxysmal A.F.:

CAD with re PCI of LAD and LCXMajor GI bleeding historyLAA closure

Operator

Aris Moschovitis
Prof. Stefan Windecker

Operator

Stephan Windecker

Hot Line data on LAA closure in Europe from the prospective 1,000 patient EWOLUTION registry

From EuroPCR 2016

Can closing the left atrial appendage (LAA) reduce the incidence of stroke and systemic embolism for higher risk patients with non-valvular AF and is this procedure both safe and effective?

That is what M. Bergmann is looking at as he summarises the 3-month findings of this dynamic pan-European registry. We take a glance at the success rates in LAA closure, periprocedural risk and the impact and safety of drug therapy after the device is implanted. The EWOLUTION registry, results here…

LIVE case: stroke prevention - LAA closure

From EuroPCR 2016

Watch this LIVE case if you want to learn more about left atrial appendage (LAA) closure.

A 87-year-old female with paroxysmal A.F.:

Cerebral hemorrhage 3 months agoLAA closure with CT and angio co-registration image

Operator

Philippe Garot
Dr. Bernard Chevalier

Operator

Bernard Chevalier

LAA closure: what's new?

18 May 2016 – From EuroPCR 2016

Chairperson

Philippe Kolh

Recorded LIVE demonstration: stroke prevention in patients with high bleeding risk - role of LAA closure

21 Jan 2016 – From AsiaPCR/SingLIVE 2016

LIVE demonstration: Combined TAVI and LAA closure using a step-by-step approach

20 Sep 2016 – From PCR London Valves 2016

Consult this lecture on combined TAVI and LAA closure using a step-by-step approach.

Dr. Jean Fajadet

Chairperson

Jean Fajadet
Michael Haude

Chairperson

Michael Haude

Interventions for hypertension and stroke

From EuroPCR 2016

With new and innovative devices coming into the specialists’ armamentarium, LAA occlusions and closure are a quickly advancing arena. Here to discuss LAA closure in general and a device which is acknowledged as “paving the way” in this space, we join D. Foley, M.W. Bergmann and H. Sievert.

Together they discuss the Watchman device and results from the prospective “real-world” EWOLUTION registry, a registry designed to “close the gap” by complementing our existing evidence and knowledge from trials on this fascinating and important clinical topic….